EFFICACY AND SAFETY OF ABT-126, AN A7 NICOTINIC CHOLINERGIC AGONIST, IN TREATMENT OF COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA: RESULTS FROM A PHASE 2B STUDY IN SMOKERS
SCHIZOPHRENIA BULLETIN（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要